Blood Cancer Awareness Month may be drawing to a close, but for HealthTree, we are taking a substantial leap forward. HealthTree is expanding its blood cancer reach from supporting multiple myeloma and myelodysplastic syndromes (MDS) to now all blood cancers.
HealthTree is poised to revolutionize the landscape of blood cancer support with the launch of HealthTree 2.0 on October, 23rd 2023. Our groundbreaking platform will now support 35 types of blood cancers, including all types of leukemia, lymphoma, and myeloproliferative neoplasms. This new era reaffirms our dedication to providing unmatched support, knowledge, and resources to a wider community of blood cancer patients and their care partners.
In addition to offering unparalleled educational resources aimed at helping patients become active members in their care, HealthTree is known for its first-of-its-kind data portal called CureHub, where its primary mission is to accelerate a cure for blood cancers. CureHub allows patients to securely share their validated diagnosis, lab values, disease genetics, patient-reported outcomes, family history, and more in a single place for researchers and scientists to analyze with the goal of accelerating research toward a cure.
For the past decade, our accomplishments in the fields of myeloma and MDS have been a source of inspiration. From helping patients access clinical trials to fostering collaboration between patients, caregivers, and medical professionals, we have strived to be a trusted ally in the battle against blood cancer. But we recognize that blood cancers come in a wide variety of forms, and our vision for a world free of blood cancers extends to every patient and every type of blood cancer.
Now, with the introduction of HealthTree 2.0, we embark on a new chapter, extending our mission to all forms of blood cancers. To view all the blood cancers that HealthTree now supports, visit www.healthtree.org. Enter your or your loved one's blood cancer name in the search bar to visit the disease-specific website and access the programs and resources that are personalized to your type of cancer.
All of our core programs and resources will be tailored thoughtfully for each of our 35 blood cancer divisions. Everything we do will lie within HealthTree 2.0’s three foundational pillars:
You can view a detailed breakdown of the programs and resources each of our 35 blood cancer divisions will have within our three pillars in the picture below. All of our new blood cancer websites will start with news, a specialist directory, HealthTree Journal, patient navigator support, HealthTree Connect, HealthTree Moves and every section of Cure Hub except treatment options. Our dedicated and passionate 60-person team will be working hard to roll out the remaining programs and resources throughout 2024!
Don't miss our virtual HealthTree 2.0 Launch Event on October 23, 2023! Join us in exploring the future of blood cancer care and discover how you can play a pivotal role in accelerating a cure for MDS and all types of blood cancer.
Register for our virtual launch today and extend the invitation to everyone you know! While you may have been affected by MDS, it's likely you also know someone else with a different type of blood cancer. By uniting together, we can reshape the landscape of blood cancer care and ensure everyone affected by blood cancer achieves a cure.
HealthTree for Acute Lymphoblastic Leukemia
HealthTree for Acute Myeloid Leukemia
HealthTree for B-Cell Prolymphocytic Leukemia
HealthTree for Blastic Plasmacytoid Dendritic Cell Neoplasm
HealthTree for Chronic Lymphocytic Leukemia
HealthTree for Chronic Myeloid Leukemia
HealthTree for Chronic Myelomonocytic Leukemia
HealthTree for Hairy Cell Leukemia
HealthTree for Large Granular Lymphocytic Leukemia
HealthTree for T-Cell Prolymphocytic Leukemia
HealthTree for Angioimmunoblastic T-Cell Lymphoma
HealthTree for Anaplastic Large Cell Lymphoma
HealthTree for Burkitt Lymphoma
HealthTree for Small-Cell Lymphocytic Lymphoma
HealthTree for Cutaneous T-Cell Lymphoma
HealthTree for Diffuse Large B-Cell Lymphoma
HealthTree for Enteropathy-Associated Intestinal T-Cell Lymphoma
HealthTree for Follicular Lymphoma
HealthTree for Extranodal Natural Killer Lymphoma
HealthTree for Hepatosplenic T-Cell Lymphoma
HealthTree for Hodgkin Lymphoma
HealthTree for Lymphoblastic Lymphoma
HealthTree for Mantle Cell Lymphoma
HealthTree for Marginal Zone Lymphoma
HealthTree for Mucosa-Associated Lymphoid Tissue Lymphoma
HealthTree for Peripheral T-Cell Lymphoma
HealthTree for Primary Mediastinal B-Cell Lymphoma
HealthTree for Waldenstrom's Macroglobulinemia
HealthTree for Myelodysplastic Syndromes
HealthTree for Essential Thrombocythemia
HealthTree for Polycythemia Vera
HealthTree for Hypereosinophilic Syndrome
Blood Cancer Awareness Month may be drawing to a close, but for HealthTree, we are taking a substantial leap forward. HealthTree is expanding its blood cancer reach from supporting multiple myeloma and myelodysplastic syndromes (MDS) to now all blood cancers.
HealthTree is poised to revolutionize the landscape of blood cancer support with the launch of HealthTree 2.0 on October, 23rd 2023. Our groundbreaking platform will now support 35 types of blood cancers, including all types of leukemia, lymphoma, and myeloproliferative neoplasms. This new era reaffirms our dedication to providing unmatched support, knowledge, and resources to a wider community of blood cancer patients and their care partners.
In addition to offering unparalleled educational resources aimed at helping patients become active members in their care, HealthTree is known for its first-of-its-kind data portal called CureHub, where its primary mission is to accelerate a cure for blood cancers. CureHub allows patients to securely share their validated diagnosis, lab values, disease genetics, patient-reported outcomes, family history, and more in a single place for researchers and scientists to analyze with the goal of accelerating research toward a cure.
For the past decade, our accomplishments in the fields of myeloma and MDS have been a source of inspiration. From helping patients access clinical trials to fostering collaboration between patients, caregivers, and medical professionals, we have strived to be a trusted ally in the battle against blood cancer. But we recognize that blood cancers come in a wide variety of forms, and our vision for a world free of blood cancers extends to every patient and every type of blood cancer.
Now, with the introduction of HealthTree 2.0, we embark on a new chapter, extending our mission to all forms of blood cancers. To view all the blood cancers that HealthTree now supports, visit www.healthtree.org. Enter your or your loved one's blood cancer name in the search bar to visit the disease-specific website and access the programs and resources that are personalized to your type of cancer.
All of our core programs and resources will be tailored thoughtfully for each of our 35 blood cancer divisions. Everything we do will lie within HealthTree 2.0’s three foundational pillars:
You can view a detailed breakdown of the programs and resources each of our 35 blood cancer divisions will have within our three pillars in the picture below. All of our new blood cancer websites will start with news, a specialist directory, HealthTree Journal, patient navigator support, HealthTree Connect, HealthTree Moves and every section of Cure Hub except treatment options. Our dedicated and passionate 60-person team will be working hard to roll out the remaining programs and resources throughout 2024!
Don't miss our virtual HealthTree 2.0 Launch Event on October 23, 2023! Join us in exploring the future of blood cancer care and discover how you can play a pivotal role in accelerating a cure for MDS and all types of blood cancer.
Register for our virtual launch today and extend the invitation to everyone you know! While you may have been affected by MDS, it's likely you also know someone else with a different type of blood cancer. By uniting together, we can reshape the landscape of blood cancer care and ensure everyone affected by blood cancer achieves a cure.
HealthTree for Acute Lymphoblastic Leukemia
HealthTree for Acute Myeloid Leukemia
HealthTree for B-Cell Prolymphocytic Leukemia
HealthTree for Blastic Plasmacytoid Dendritic Cell Neoplasm
HealthTree for Chronic Lymphocytic Leukemia
HealthTree for Chronic Myeloid Leukemia
HealthTree for Chronic Myelomonocytic Leukemia
HealthTree for Hairy Cell Leukemia
HealthTree for Large Granular Lymphocytic Leukemia
HealthTree for T-Cell Prolymphocytic Leukemia
HealthTree for Angioimmunoblastic T-Cell Lymphoma
HealthTree for Anaplastic Large Cell Lymphoma
HealthTree for Burkitt Lymphoma
HealthTree for Small-Cell Lymphocytic Lymphoma
HealthTree for Cutaneous T-Cell Lymphoma
HealthTree for Diffuse Large B-Cell Lymphoma
HealthTree for Enteropathy-Associated Intestinal T-Cell Lymphoma
HealthTree for Follicular Lymphoma
HealthTree for Extranodal Natural Killer Lymphoma
HealthTree for Hepatosplenic T-Cell Lymphoma
HealthTree for Hodgkin Lymphoma
HealthTree for Lymphoblastic Lymphoma
HealthTree for Mantle Cell Lymphoma
HealthTree for Marginal Zone Lymphoma
HealthTree for Mucosa-Associated Lymphoid Tissue Lymphoma
HealthTree for Peripheral T-Cell Lymphoma
HealthTree for Primary Mediastinal B-Cell Lymphoma
HealthTree for Waldenstrom's Macroglobulinemia
HealthTree for Myelodysplastic Syndromes
HealthTree for Essential Thrombocythemia
HealthTree for Polycythemia Vera
HealthTree for Hypereosinophilic Syndrome
about the author
Katie Braswell
Katie joined HealthTree as the Community Director for AML in 2021. She is a registered dietitian who previously worked at the VA hospital in Dallas, Texas where she coached veterans with blood cancer on how to use nutrition to improve their treatment outcomes and minimize cancer-related side effects. Katie is passionate about health education and patient empowerment. In her spare time, she loves to experiment with new recipes in the kitchen, spend time running outdoors and travel to new places.
Subscribe to the weekly newsletter for news, stories, clinical trial updates, and helpful resources and events with cancer experts.